<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="335929">
  <stage>Registered</stage>
  <submitdate>6/09/2010</submitdate>
  <approvaldate>7/09/2010</approvaldate>
  <actrnumber>ACTRN12610000745044</actrnumber>
  <trial_identification>
    <studytitle>How useful is spirometry during and following exacerbations of chronic obstructive pulmonary disease?</studytitle>
    <scientifictitle>For patients admitted for a suspected exacerbation of chronic obstructive pulmonary disease (COPD), does use of spirometry compared with no spirometry influence diagnosis and management, and is it predictive of outcomes?</scientifictitle>
    <utrn />
    <trialacronym />
    <secondaryid>N/A</secondaryid>
  </trial_identification>
  <conditions>
    <healthcondition>COPD exacerbations</healthcondition>
    <conditioncode>
      <conditioncode1>Respiratory</conditioncode1>
      <conditioncode2>Chronic obstructive pulmonary disease</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Spirometry- once consented, the researcher will approach the patient at the bedside to perform spirometry with a hand-held portable spirometer and measure the usual values of forced expiratory volume in 1 second (FEV1), forced vital capacity (FVC), forced expiratory ratio (FER), inspiratory capacity (IC) etc. This will first occur within 24 hours of admission and then daily until discharge, and again at a 4 week follow-up. Testing should take around 30mins each time.</interventions>
    <comparator>Intention-to-treat, no additional testing will be done</comparator>
    <control>Active</control>
    <interventioncode>Diagnosis / Prognosis</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>Length of hopsital stay, determined by admission and discharge time</outcome>
      <timepoint>at discharge</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>Change in initial diagnosis compared to discharge (final)diagnosis, determined from admission and discharge notes</outcome>
      <timepoint>admission and discharge</timepoint>
    </primaryOutcome>
    <primaryOutcome>
      <outcome>treatment success or failure, success being discharge without futher complications and failure being need for mechanical ventilation and/or intensive care</outcome>
      <timepoint>at discharge or if treatment fails, at onset of mechanical ventilation/intensive care</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>differences in management, e.g. medications and referrals. between test and control groups, determined from medical records</outcome>
      <timepoint>at discharge and 4 week follow-up</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>current/ex smokers - 10 year pack history
hospital admission diagnosis of COPD exacerbation</inclusivecriteria>
    <inclusiveminage>50</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>0</inclusivemaxage>
    <inclusivemaxagetype>No limit</inclusivemaxagetype>
    <inclusivegender>Both males and females</inclusivegender>
    <healthyvolunteer>No</healthyvolunteer>
    <exclusivecriteria>Non-english speaking
Confused/comatose/unable to follow instructions
Requiring mechanical ventilation/intensive care</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Diagnosis</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment />
    <sequence />
    <masking />
    <assignment />
    <designfeatures />
    <endpoint />
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>7/09/2010</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>48</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Not yet recruiting</recruitmentstatus>
    <recruitmentcountry>Australia</recruitmentcountry>
    <recruitmentstate />
  </recruitment>
  <sponsorship>
    <primarysponsortype>Commercial sector/Industry</primarysponsortype>
    <primarysponsorname>GlaxoSmithKline (GSK)</primarysponsorname>
    <primarysponsoraddress>82 Hughes Avenue
Ermington, NSW 2115</primarysponsoraddress>
    <primarysponsorcountry>Australia</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>University of Melbourne</fundingname>
      <fundingaddress>The University of Melbourne
Victoria 3010</fundingaddress>
      <fundingcountry>Australia</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>None</sponsortype>
      <sponsorname />
      <sponsoraddress />
      <sponsorcountry />
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>A simple breathing test, called spirometry, provides valuable information in the diagnosis and assessment of many lung diseases, including chronic obstructive pulmonary disease (COPD). There is little knowledge regarding usefulness of this test during COPD exacerbations requiring hospitalisations, and so is rarely performed. The purpose of this study is to assess how useful it is to perform spirometry in this setting.</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>Austin Health Human Research Ethics Committee</ethicname>
      <ethicaddress>145 Studley Road
Heidelberg
Victoria 3084</ethicaddress>
      <ethicapprovaldate>1/09/2010</ethicapprovaldate>
      <hrec>H2010/03972</hrec>
      <ethicsubmitdate />
      <ethiccountry>Australia</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>Bob Zhang</name>
      <address>145 Studley Road
PO Box 5555 
Heidelberg
Victoria 3084</address>
      <phone>+61 3 94963720</phone>
      <fax />
      <email>bob.zhang@austin.org.au</email>
      <country>Australia</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>Bob Zhang</name>
      <address>145 Studley Road
PO Box 5555 
Heidelberg
Victoria 3084</address>
      <phone>+61 3 94963720</phone>
      <fax />
      <email>bob.zhang@austin.org.au</email>
      <country>Australia</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>